PROK

ProKidney Corp. Class A Ordinary Shares

1.65

USD

-0.18

-9.84%

Sep 23, 15:57 UTC -4

Closed

After-Market

1.72

+0.07

+4.12%

PROK Earnings Reports

Positive Surprise Ratio

PROK beat 12 of 16 last estimates.

75%

Next Report

Date of Next Report

Nov 09, 2026

Estimate for Q3 26 (Revenue/ EPS)

$127.09K

-$0.14

Implied change from Q2 26 (Revenue/ EPS)

-15.27%

-6.67%

Implied change from Q3 25 (Revenue/ EPS)

-41.43%

+16.67%

ProKidney Corp. Class A Ordinary Shares earnings per share and revenue

On Aug 10, 2026, PROK reported earnings of -0.15 USD per share (EPS) for Q2 26, missing the estimate of -0.14 USD, resulting in a -4.53% surprise. Revenue reached 150.00 thousand, compared to an expected 151.98 thousand, with a -1.30% difference. The market reacted with a -4.73% price change (close before vs. close after earnings).

Looking ahead to Q3 26, -- analysts forecast an EPS of -0.14 USD, with revenue projected to reach 127.09 thousand USD, implying an decrease of -6.67% EPS, and decrease of -15.27% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Champions Oncology, Inc.

Report Date

Sep 10, 2026 For Q1 27

Estimate

-$0.01

Actual

-$0.03

Surprise

-194.12%

PharmaCyte Biotech, Inc. Common Stock

Report Date

Sep 14, 2026 For Q1 27

Estimate

Actual

-$0.54

Surprise

FAQ

What were ProKidney Corp. Class A Ordinary Shares's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, ProKidney Corp. Class A Ordinary Shares reported EPS of -$0.15, missing estimates by -4.53%, and revenue of $150.00K, -1.3% below expectations.

How did the market react to ProKidney Corp. Class A Ordinary Shares's Q2 2026 earnings?

The stock price moved down -4.73%, changed from $1.69 before the earnings release to $1.61 the day after.

When is ProKidney Corp. Class A Ordinary Shares expected to report next?

The next earning report is scheduled for Nov 09, 2026.

What are the forecasts for ProKidney Corp. Class A Ordinary Shares's next earnings report?

Based on -- analysts, ProKidney Corp. Class A Ordinary Shares is expected to report EPS of -$0.14 and revenue of $127.09K for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.